Target Trial Emulation and Bias Through Missing Eligibility Data: An Application to a Study of Palivizumab for the Prevention of Hospitalization due to Infant Respiratory Illness. (2022)

First Author: Tompsett D

Attributed to: HOD1: Comparative Effectiveness Research using Observational Data:Methodological Developments and a Roadmap (CER-OBS) funded by MRC

No abstract provided

Type: Journal Article/Review

Volume: TBD

Parent Publication: American Journal of Epidemiology

Issue: TBD